Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: An in vivo microdialysis study

Brain Research

Volumn 948, Issue 1-2, 2002, Pages 155-158

  Pistis, Marco ^a   Ferraro, Luca ^b   Pira, Luigi ^c   Flore, Giovanna ^a   Tanganelli, Sergio ^b   Gessa, Gian Luigi ^a,c   Devoto, Paola ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Neuroscienze PharmaNess Scarl   (Italy)

Author keywords

Aminobutyric acid; Cannabinoid; Dopamine; Glutamate; In vivo microdialysis; Prefrontal cortex

Indexed keywords

4 AMINOBUTYRIC ACID; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE; DRONABINOL; GLUTAMIC ACID; NEUROTRANSMITTER; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; DOPAMINE; EXTRACELLULAR SPACE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MICRODIALYSIS; PIPERIDINES; PREFRONTAL CORTEX; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0037032111     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03055-X     Document Type: Article

References (27)

1. Auclair N., Otani S., Soubrie P., Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 83:2000;3287-3293.
2. Carr D.B., Sesack S.R. Callosal terminals in the rat prefrontal cortex: synaptic targets and association with GABA-immunoreactive structures. Synapse. 29:1998;193-205.
3. Carr D.B., Sesack S.R. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse. 38:2000;114-123.
4. Chen J., Paredes W., Lowinson J.H., Gardner E.L. Δ9-Tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol. 190:1990;259-262.
5. 3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience. 103:2001;9-15.
6. Diana M., Melis M., Gessa G.L. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur. J. Neurosci. 10:1998;2825-2830.
7. Ferraro L., Tomasini M.C., Gessa G.L., Bebe B.W., Tanganelli S., Antonelli T. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb. Cortex. 11:2001;728-733.
8. Ferraro L., Tomasini M.C., Cassano T., Bebe B.W., Siniscalchi A., O'Connor W.T., Magee P., Tanganelli S., Cuomo V., Antonelli T. Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J. Neurosci. Res. 66:2001;298-302.
9. Gessa G.L., Devoto P., Diana M., Flore G., Melis M., Pistis M. Dissociation of haloperidol, clozapine and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology. 22:2000;642-649.
10. Goldman-Rakic P.S. Cellular basis of working memory. Neuron. 14:1995;477-485.
11. Gurden H., Takita M., Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J. Neurosci. 20:2000;RC106.
12. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiography study. J. Neurosci. 11:1991;563-583.
13. Hollister L.E. Health aspects of cannabis: revisited. Int. J. Neuropsychopharmcol. 1:1998;71-80.
14. Jentsch J.D., Andrusiak E., Tran A., Bowers M.B. Jr., Roth R.H. Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology. 16:1997;426-432.
15. Katona I., Sperlágh B., Sík A., Käfalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:1999;4544-4558.
16. Katona I., Sperlagh B., Magloczky Z., Santha E., Kofalvi A., Czirjak S., Mackie K., Vizi E.S., Freund T.F. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience. 100:2000;797-804.
17. Kuroda M., Yokofujita J., Murakami K. An ultrastructural study of the neural circuit between the prefrontal cortex and the mediodorsal nucleus of the thalamus. Prog. Neurobiol. 54:1998;417-458.
18. Levenes C., Daniel H., Soubrie P., Crepel F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J. Physiol. 510:1998;867-879.
19. Leweke F.M., Giuffrida A., Wurster U., Emrich H.M., Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 10:1999;1665-1669.
20. Lichtman A.H., Martin B.R. Delta-9 tetrahydrocannabinol impairs spatial working memory through a cannabinoid receptor mechanism. Psychopharmacology. 126:1996;125-131.
21. Mallet P.E., Beninger R.J. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav. Pharmacol. 7:1996;276-284.
22. Nakamura E.M., da Silva E.A., Concilio G.V., Wilkinso D.A., Masur J. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend. 28:1991;167-175.
23. Paxinos G., Watson C. The rat brain in stereotaxic co-ordinates. 3rd Edition:1997;Academic Press, San Diego, CA.
24. Pistis M., Porcu G., Melis M., Diana M., Gessa G.L. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. Eur. J. Neurosci. 14:2001;96-102.
25. H.G. Pope, D. Yurgelund-Todd, The residual cognitive effects of heavy marijuana use in college students, J. Am. Med. Assoc. (1996) 521-527.
26. Rolls E.T. The orbitofrontal cortex and reward. Cereb. Cortex. 10:2000;284-294.
27. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16:1996;4322-4334.